• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Switching From High-Dose, Long-Term Opioids to Buprenorphine: A Case Series.

作者信息

Becker William C, Frank Joseph W, Edens Ellen L

机构信息

Yale School of Medicine and VA Connecticut Healthcare System, West Haven, Connecticut (W.C.B., E.L.E.).

University of Colorado School of Medicine and VA Eastern Colorado Health Care System, Aurora, Colorado (J.W.F.).

出版信息

Ann Intern Med. 2020 Jul 7;173(1):70-71. doi: 10.7326/L19-0725. Epub 2020 Apr 7.

DOI:10.7326/L19-0725
PMID:32252072
Abstract
摘要

相似文献

1
Switching From High-Dose, Long-Term Opioids to Buprenorphine: A Case Series.从高剂量、长期阿片类药物转换为丁丙诺啡：病例系列
Ann Intern Med. 2020 Jul 7;173(1):70-71. doi: 10.7326/L19-0725. Epub 2020 Apr 7.
2
Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study.羟考酮缓释片治疗慢性下腰痛的疗效与安全性：一项随机、双盲、安慰剂对照及活性药物对照的III期研究结果
J Pain. 2005 Jan;6(1):21-8. doi: 10.1016/j.jpain.2004.09.005.
3
Efficacy and safety of buprenorphine transdermal system (BTDS) for chronic moderate to severe low back pain: a randomized, double-blind study.丁丙诺啡透皮贴剂（BTDS）治疗慢性中重度下腰痛的疗效和安全性：一项随机、双盲研究。
J Pain. 2011 Nov;12(11):1163-73. doi: 10.1016/j.jpain.2011.06.003. Epub 2011 Jul 31.
4
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).阿片类药物与老年人慢性重度疼痛的管理：一个国际专家小组的共识声明，重点关注世界卫生组织第三阶梯临床最常用的六种阿片类药物（丁丙诺啡、芬太尼、氢吗啡酮、美沙酮、吗啡、羟考酮）。
Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.
5
[Pain therapy in the elderly:7-day transdermal buprenorphine patch in clinical practice. Results of a non-interventional study].[老年疼痛治疗：临床实践中使用7天透皮丁丙诺啡贴剂。一项非干预性研究的结果]
MMW Fortschr Med. 2013 Mar 21;155 Suppl 1:25-31. doi: 10.1007/s15006-013-0733-3.
6
Behavioral Effects of Opioid Full and Partial Agonists During Chronic Buprenorphine Treatment.阿片类药物完全激动剂和部分激动剂在慢性丁丙诺啡治疗期间的行为效应。
J Pharmacol Exp Ther. 2019 Nov;371(2):544-554. doi: 10.1124/jpet.119.259010. Epub 2019 Aug 14.
7
Switching from high doses of pure μ-opioid agonists to transdermal buprenorphine in patients with cancer: a feasibility study.癌症患者从高剂量纯μ-阿片受体激动剂转换为透皮丁丙诺啡的可行性研究。
J Opioid Manag. 2013 Jul-Aug;9(4):255-62. doi: 10.5055/jom.2013.0166.
8
Pharmacokinetic and pharmacodynamic evaluation of oxycodone and naltrexone for the treatment of chronic lower back pain.羟考酮和纳曲酮治疗慢性下腰痛的药代动力学和药效学评价
Expert Opin Drug Metab Toxicol. 2016 Jul;12(7):823-31. doi: 10.1080/17425255.2016.1191469. Epub 2016 Jun 7.
9
New Initiation of Long-Acting Opioids in Long-Stay Nursing Home Residents.长期居住在养老院的居民中长效阿片类药物的新启用情况。
J Am Geriatr Soc. 2016 Sep;64(9):1772-8. doi: 10.1111/jgs.14306. Epub 2016 Aug 3.
10
Decreased responsiveness to oxycodone: A case of a pharmacokinetic drug interaction?
J Opioid Manag. 2015 Jul-Aug;11(4):357-61. doi: 10.5055/jom.2015.0284.

引用本文的文献

1
Buprenorphine, Pain, and Opioid Use in Patients Taking High-Dose Long-Term Opioids: A Randomized Clinical Trial.丁丙诺啡、疼痛与长期服用高剂量阿片类药物患者的阿片类药物使用：一项随机临床试验
JAMA Intern Med. 2025 Apr 1;185(4):372-381. doi: 10.1001/jamainternmed.2024.8361.
2
Low-dose Initiation of Buprenorphine/naloxone for the Management of Chronic Non-cancer Pain in Patients on Long-term Opioid Therapy: A Case Series.低剂量起始丁丙诺啡/纳洛酮用于长期阿片类药物治疗患者慢性非癌性疼痛的管理：病例系列
Can J Pain. 2024 Jan 26;8(1):2310811. doi: 10.1080/24740527.2024.2310811. eCollection 2024.
3
The design and baseline characteristics for the HOPE Consortium Trial to reduce pain and opioid use in hemodialysis.
HOPE 联盟试验的设计和基线特征旨在减轻血液透析患者的疼痛和阿片类药物使用。
Contemp Clin Trials. 2024 Jan;136:107409. doi: 10.1016/j.cct.2023.107409. Epub 2023 Dec 10.
4
Patient Motivation to Reduce or Discontinue Opioids for Chronic Pain: Self-efficacy, Barriers, and Readiness to Change.慢性疼痛患者减少或停用阿片类药物的动机：自我效能、障碍及改变的准备情况
Clin J Pain. 2024 Jan 1;40(1):18-25. doi: 10.1097/AJP.0000000000001167.
5
Video-telecare collaborative pain management during COVID-19: a single-arm feasibility study.新冠疫情期间的视频远程协作式疼痛管理：一项单臂可行性研究。
BMC Prim Care. 2023 Jun 29;24(1):134. doi: 10.1186/s12875-023-02052-2.
6
Low dose IV buprenorphine inductions for patients with opioid use disorder and concurrent pain: a retrospective case series.低剂量 IV 丁丙诺啡诱导治疗合并疼痛的阿片类药物使用障碍患者：一项回顾性病例系列研究。
Addict Sci Clin Pract. 2023 Jun 1;18(1):38. doi: 10.1186/s13722-023-00392-z.
7
Buprenorphine Microdosing Cross Tapers: A Time for Change.丁丙诺啡微量滴定交叉递减法：变革之时。
Int J Environ Res Public Health. 2022 Dec 8;19(24):16436. doi: 10.3390/ijerph192416436.
8
Efficacy of interventions to reduce long term opioid treatment for chronic non-cancer pain: systematic review and meta-analysis.干预措施减少慢性非癌痛长期阿片类药物治疗的疗效：系统评价和荟萃分析。
BMJ. 2022 Apr 4;377:e066375. doi: 10.1136/bmj-2021-066375.
9
Buprenorphine initiation strategies for opioid use disorder and pain management: A systematic review.阿片类物质使用障碍和疼痛管理中丁丙诺啡的起始策略：系统评价。
Pharmacotherapy. 2022 May;42(5):411-427. doi: 10.1002/phar.2676. Epub 2022 Mar 25.
10
A Review: The Manifestations, Mechanisms, and Treatments of Musculoskeletal Pain in Patients With COVID-19.综述：新型冠状病毒肺炎患者肌肉骨骼疼痛的表现、机制及治疗
Front Pain Res (Lausanne). 2022 Mar 10;3:826160. doi: 10.3389/fpain.2022.826160. eCollection 2022.